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Abstract
Thyroid ultrasonography (US) is the gold standard for thyroid imaging and its widespread use is due to an optimal spatial 
resolution for superficial anatomic structures, a low cost and the lack of health risks. Thyroid US is a pivotal tool for the 
diagnosis and follow-up of autoimmune thyroid diseases, for assessing nodule size and echostructure and defining the risk 
of malignancy in thyroid nodules. The main limitation of US is the poor reproducibility, due to the variable experience of 
the operators and the different performance and settings of the equipments. Aim of this consensus statement is to standardize 
the report of thyroid US through the definition of common minimum requirements and a correct terminology. US patterns of 
autoimmune thyroid diseases are defined. US signs of malignancy in thyroid nodules are classified and scored in each nodule. 
We also propose a simplified nodule risk stratification, based on the predictive value of each US sign, classified and scored 
according to the strength of association with malignancy, but also to the estimated reproducibility among different operators.
Keywords Thyroid · Thyroid nodules · Thyroid ultrasonography · Autoimmune thyroiditis · Graves’ disease · Thyroid 
cancer
Introduction
Thyroid ultrasonography (US) is the gold standard for thy-
roid imaging and its widespread use is due to an optimal 
spatial resolution for superficial anatomic structures, a low 
cost and the lack of health risks. Thyroid US is currently 
used for the diagnosis and follow-up of diffuse or focal thy-
roid illnesses such as Hashimoto’s thyroiditis [1, 2], Graves’ 
disease [3, 4], goiter and thyroid nodules [5–9].
Thyroid hypoechogenicity has been shown to be indica-
tive of thyroid autoimmunity, due to a diffuse lympho-
cytic infiltration that disrupts the normal array of thyroid 
 * T. Rago 
 rago@endoc.med.unipi.it
1 Endocrinology Unit, Dept. Clinical and Experimental 
Medicine, University of Pisa, Via Paradisa, 2, 56124 Pisa, 
Italy
2 Dept. of Radiological Science, Policlinico Umberto I, 
University Sapienza, Viale del Policlinico, 155, Rome 00161, 
Italy
3 Endocrinology Unit, University Cattolica del Sacro Cuore, 
Largo Agostino Gemelli, 8, Rome 00168, Italy
4 Internal Medicine and Endocrinology Unit - ICS Maugeri, 
IRCCS, University of Pavia, Via S. Maugeri, 4, Pavia 27100, 
Italy
5 Endocrinology, Diabetology and Metabolism Unit, 
Dept. Medical Science, University of Torino, Via Magellano, 
1, Turin 10128, Italy
6 Dept. of Internal Medicine and Medical Specialties, 
University Sapienza, Viale del Policlinico, 155, Rome 00161, 
Italy
7 Endocrinology Unit, Arcispedale S. Maria Nuova, IRCCS, 
Viale Risorgimento, 80, Reggio Emilia 42123, Italy
8 Endocrine Surgery, Ospedale del Mare, Via Enrico Russo, 
Naples 80147, Italy
9 Dept. of Advanced Biomedical Science, University of Naples 
Federico II, Corso Umberto I, 40, Naples 80128, Italy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
A1
A2
A3
A4
A5
A6
A7
A8
A9
A10
A11
A12
A13
A14
A15
A16
A17
A18
A19
A20
A21
A22
A23
A24
A25
     
    R
EV
ISE
D P
RO
OF
Journal : Large 40618 Article No : 935 Pages : 9 MS Code : JENI-D-18-00315 Dispatch : 11-10-2018
 Journal of Endocrinological Investigation
1 3
parenchyma in Hashimoto’s thyroiditis or to the microfol-
licular pattern and increased vascularity in Graves’ disease 
[3–10]. Thyroid hypoechogenicity at ultrasound helps to 
identify patients who have a diffuse Hashimoto’s thyroiditis 
among a larger group of patients with goiter and circulating 
thyroid autoantibodies [3]. The pattern of thyroid hypoecho-
genicity at ultrasound was shown to have a higher sensitiv-
ity than thyroid autoantibody positivity for diagnosing or 
predicting hypothyroidism and hyperthyroidism [11, 12].
In nodular thyroid disease, conventional US provides 
information regarding the size of nodules and defines pat-
terns correlated with the risk of cancer. Several studies have 
been conducted to establish the usefulness of thyroid US in 
the diagnosis of benign versus malignant thyroid nodules 
[5–8, 13–15]. The US features more frequently associated 
with thyroid carcinoma are hypoechogenicity, absence of 
a halo sign, the presence of microcalcifications, a “taller 
than wide” shape [13–18]. However, the sensitivity, speci-
ficity, and accuracy of these US signs are extremely vari-
able in the literature. It is widely recognized that any single 
ultrasound pattern cannot be considered specific for malig-
nancy. Rago et al. demonstrated that one single parameter is 
weakly predictive of malignancy, while the combination of 
US features has a higher specificity than any single pattern, 
but this gain of specificity is achieved at the expense of a 
lower sensitivity [13]. Most scientific societies agree that 
US feature should support the indication to perform fine 
needle aspiration (FNA). To this purpose, several classifica-
tion systems have been proposed with the aim to stratify the 
risk of cancer in thyroid nodules [7, 19–25]. Some of these 
systems were termed TI-RADS (Thyroid Imaging, Report-
ing and Data System) because they were modeled according 
to the American Committee of Radiology BI-RADS, which 
has been widely accepted in breast imaging. Some socie-
ties, such as the American Thyroid Association (ATA), have 
taken a slightly different, pattern-oriented approach [6]. The 
plethora, complexity, and lack of congruence of these sys-
tems have limited their adoption in the clinical practice. Fur-
thermore, the comparison of the scoring systems currently 
proposed has shown relevant differences in the stratification 
of risk [26, 27].
Aside the well-recognized advantage, thyroid US has also 
drawbacks such as the poor reproducibility, due to differ-
ences in the equipments used, and a lack of a standardized 
US reporting. To fully capitalize the diagnostic capabilities 
of an ultrasound examination in the context of thyroid dis-
ease, the purpose of this consensus statement is to stand-
ardize the report of thyroid US through the definition of 
common minimum requirements and a correct terminology.
Thyroid US methodology
Thyroid US is performed with the patient lying in the 
supine position and having his/her neck extended. A high-
frequency (7.5–14 MHz) linear transducer, along with 
color flow or power Doppler examination, is used. Limi-
tations exist for large thyroid glands, such as multinodular 
sub-sternal goiters, and for the upper mediastinum explo-
ration, which may benefit from additional scans using a 
6-MHz linear transducer or a 3–5-MHz convex transducer. 
Elastosonography, a tool nowadays available in a grow-
ing fraction of modern US equipments, may add useful 
information in the evaluation of thyroid nodules (Fig. 2). 
(a) Perform a thorough transverse US scanning from the 
sub-lingual position to the subclavicular region, start-
ing with a global assessment of the thyroid gland and 
obtaining an anatomical overview of its relation with 
the central neck structures.
(b) Using transverse and longitudinal US scanning, focus 
on the location, size, shape, margins and echostruc-
ture of the right and left lobe and isthmus. Detect the 
presence of focal lesions, their precise location, size, 
morphology, vascularization and elasticity by elasto-
sonography, if available.
(c) Using transverse US scanning, perform a global assess-
ment of the central and cervical lymph nodes. Start 
from the sub-mental group (level Ia) to the central 
compartment (level VI) until the subclavicular region. 
Then move to the sub-mandibular group (level Ib) 
and, maintaining as anatomical reference the jugular 
carotid short axis, explore II–III–IV levels (respec-
tively, upper–medium–lower jugular groups). There-
after, scan transversely from the sternocleidomastoid 
muscle to the supraclavicular region to explore the V 
level (posterior triangle group), on both sides. Focus 
on clinically relevant lymph nodes obtaining transverse 
and longitudinal scanning parallel to the long axis to 
evaluate size, morphology and vascularization.
(d) Evaluate any accessory pathological findings in the 
thyroid nearby space (e.g. parathyroid glands, salivary 
glands, vessels).
Rules for US reporting
(a) Images should be labeled stating the patient’s name and 
facility identification, the examination date, the ana-
tomic site and side.
(b) Describe thyroid position and shape when abnormal. 
Report the size of the thyroid gland (through estima-
tion of the thyroid volume or the maximum diameter 
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
     
    R
EV
ISE
D P
RO
OF
Journal : Large 40618 Article No : 935 Pages : 9 MS Code : JENI-D-18-00315 Dispatch : 11-10-2018
Journal of Endocrinological Investigation 
1 3
of depth, width and length, the parenchymal echostruc-
ture, echogenicity and vascularization (Table 1).
(c) Focus on the presence of focal lesions within the thy-
roid, which should be defined as thyroid nodules or 
pseudo-nodules and report their precise location, mor-
phology and vascularization (Table 2). Report the pre-
cise location of thyroid nodules when more than one 
is detected. It will allow avoiding mistakes in guiding 
fine needle aspiration (FNA) and will guarantee inter-
observer agreement in the US follow-up. In multinodu-
lar goiter report dominant and/or suspicious nodule(s). 
Describe them following a predetermined order, e.g. 
from the top to the bottom of the right lobe, the left 
lobe and then the isthmus (the thyroid nodules can be 
numbered to help their identification). Optionally, add 
a schematic representation of thyroid lesions along with 
the US report. Most importantly, add for each thyroid 
nodule an estimation of the US risk of malignancy (see 
below).
(d) Report position, size and features of clinically relevant 
lymph nodes (Table 3), pointing out the suspicious 
one(s).
(e) Report accessory pathological findings in the thyroid 
nearby space (e.g. hyperplastic/adenomatous, parathy-
roid glands, abnormal salivary glands, vessels).
US report in autoimmune thyroid diseases (ATD) 
(Figs. 1, 2, 3, 4, 5)
The echographic pattern of ATD is due to the pathologi-
cal changes typical of these conditions. Hashimoto’s thy-
roiditis is characterized by lymphocytic infiltration of the 
gland with lymphoid follicles replacing thyroid follicles 
and reducing the follicular cell/colloid interface, the main 
factor of the peculiar echogenicity of a normal thyroid 
parenchyma [1, 2]. The degree of lymphocytic infiltration 
and fibrosis is the main determinant of the different echo-
genic patterns observed in Hashimoto’s patients. Graves’ 
disease is characterized by hypercellularity, scanty col-
loid and hypervascularization resulting in a similar hypo-
echoic pattern [3, 4]. The hypoechoic pattern is a useful 
sign both for diagnosis in patients with Hashimoto’s thy-
roiditis and negative serum thyroid autoantibodies and 
Table 1  US report of the thyroid gland
a A standardized order of the diameters should be used: antero-posterior (AP), transverse (T), longitudinal (L) diameter. This will likely avoid 
ambiguity, as well as ensure that subsequent measurements of the same structure are recorded in a similar fashion, even though in different set-
tings
b Thyroid volume is estimated summing the volume of each lobe calculated by the ellipsoid formula (AP × T × L × 0.52). Report isthmus size 
if AP diameter is > 0.5 cm. The normal thyroid volume varies with age, sex and geographic area. In Italy (borderline iodine sufficient area) the 
mean estimated thyroid volume was 12.9 ± 3.6 and 9.2 ± 2.9 ml in males and females, respectively [10]. Goiter is defined when thyroid volume is 
greater than the mean + 2 SD in each sex [males: > 20.1 (12.9 ±7.2) ml; females: > 15 (9.2 ± 5.8) ml]
1. Position Normal location
Mediastinal extension
2. Shape Normal shape
Presence of lobe asymmetry
Presence of thyroid anatomic variants (lobe agenesis, ectopic thyroid, pyramidal lobe, thyroglos-
sal duct nodule or cyst, Zuckerkandl’s tubercle)
3. Size Report the three diameters for each lobe in  mma
Report thyroid volume in  mlb
4. Echotexture (echoes distribution) Homogeneous: uniform appearance of the thyroid parenchyma
Heterogeneous: non-uniform appearance of the parenchyma, due to an irregular echo pattern 
showing numerous micro-nodules or echogenic septa
5. Echogenicity (echoes brightness) Normal echogenicity: higher echogenicity compared to pre-thyroid (neck strap) muscles, similar/
slightly higher echogenicity compared to salivary glands [1, 2]
Hypoechogenicity: diffusely reduced echogenicity of thyroid parenchyma
Mild: thyroid parenchyma slightly darker than normal
Moderate: thyroid parenchyma clearly darker, but less dark than neck strap muscles
Marked: thyroid parenchyma clearly darker, similar or higher than neck strap muscles
6. Vascular pattern (color and power Doppler) Pattern 0 (reduced): parenchymal flow is absent or limited to few sub-capsular vessels
Pattern 1 (normal): prevalent blood flow in main peripheral thyroid arteries and sub-capsular 
vessels, with scarce parenchymal blood flow with patchy, uneven distribution
Pattern 2 (moderately increased): clearly increased parenchymal blood flow with patchy distribu-
tion
Pattern 3 (“thyroid inferno”): markedly increased blood flow with diffuse homogeneous distribu-
tion [9]
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Table 2  US report in nodular thyroid disease
1. Position Superior/medium/inferior, anterior/posterior, paraisthmic/isthmic, define if close to the thyroid capsule (sub-
capsular)
2. Size Report the three diameters for each nodule (depth or AP, width or T, length or L)
3. Shape Round: equal length of the three diameters
Oval: depth less than width and depth less than length
Irregular: neither oval nor round, including ‘taller than wide’ (depth > width) and ‘taller than long’ 
(depth > length) shape
4. Composition Solid: composed almost entirely of solid tissue with < 10% liquid
Mixed predominantly solid: liquid component > 10% but < 50%
Mixed predominantly cystic: liquid component > 50% but < 90%
Cystic: composed entirely or nearly entirely of liquid (> 90%)
Spongiform appearance: tiny cystic spaces separated by thin septa
5. Echotexture Homogeneous: uniform appearance of parenchyma
Heterogeneous: non-uniform appearance of parenchyma
6. Echogenicity of solid nodule Isoechoic: brightness similar to the surrounding thyroid parenchyma. When the echogenicity of the surrounding 
thyroid tissue is decreased, such as in Hashimoto’s thyroiditis, the echogenicity can be compared to that of the 
sub-mandibular salivary glands
Hyperechoic: brighter appearance in comparison with the surrounding thyroid parenchyma
Mildly hypoechoic: darker appearance in comparison with the surrounding thyroid parenchyma, but less dark 
than neck strap muscles
Markedly hypoechoic: dark appearance, similar or higher than that of the neck strap muscles
7. Margins Smooth margins: clear demarcation with respect to the surrounding thyroid parenchyma
Ill-defined margins: lack of clear demarcation with respect to the surrounding thyroid parenchyma. Ill-defined 
margins are distinct from irregular margins and do not alter the nodule risk category
Irregular margins: presence of one or more sharp angles of the margins (spiculated) or presence of one or more 
smooth focal round protrusions of the margins (lobulated)
Halo/rim: describe as thin or thick, partial or complete
8. Calcifications Macrocalcification: > 1 mm coarse calcifications with posterior acoustic shadowing
Egg shell calcifications: echogenic line surrounding the nodule giving an appearance of discrete calcified wall, 
along with marked posterior acoustic shadowing
Microcalcifications: < 1 mm most often round calcifications, without acoustic shadowing
9. Accessory features Comet tail: reverberation artifacts within cystic component
Extracapsular invasion: interruption of thyroid capsule
10. Elastosonography Score 1: nodules with high elasticity
Score 2: nodules with inhomogeneous distribution
Score 3: nodules with high stiffness
Report strain ratio or Kpa-M/s (if shear wave available) > cut-off values, depending on the equipment used and 
more recent literature [30–35]
11. Vascularity Type I: absence of intranodular or perinodular flow
Type II: presence of perinodular and/or slight intranodular flow
Type III: presence of marked intranodular flow [36]
Table 3  US report in lymph-
nodes 1. Size Report the 3 diameters for each lymph-node (depth or AP, width or T, length or L)
2. Position Superior, medium, inferior, in lateral-cervical position, lateral or medial to carotid 
artery/jugular vein, in central compartment or latero-cervical levels (from I to 
VI) [38]
3. Features Typical shape/echostructure: oval shape, presence of the hilum
Atypical shape/echostructure
Indeterminate: round shape, absence of hilum
Suspicious: solid pattern with echogenicity similar to the thyroid nodule; presence 
of micro-macrocalcifications; cystic or mixed appearance; irregular (chaotic) 
vascularization
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for predicting the risk of developing hypothyroidism in 
patients with goiter and circulating thyroid autoantibod-
ies [1, 12].
The typical US pattern of Hashimoto’s thyroiditis is a 
hypoechoic thyroid gland with hyperechoic fibrous septa 
crossing the parenchyma. Lymphocytic infiltration may 
also cause a pseudo-nodular pattern with multiple discrete 
hypoechoic areas. On the other hand, solid hyperechoic 
areas can also be detected in a diffusely hypoechoic paren-
chyma representing areas spared from lymphocytic infil-
tration. These also are often referred to as pseudo-nodules. 
We recommend reporting the above findings as hypoechoic 
or hyperechoic areas, respectively, rather than nodules. 
These areas should receive a thorough examination to keep 
them distinguished from “true” thyroid nodules.
Fig. 1  Autoimmune thyroiditis. Longitudinal section: enlarged thy-
roid lobe with diffuse, homogeneous and moderate hypoechogenicity
Fig. 2  Autoimmune thyroiditis. Longitudinal section: enlarged thy-
roid lobe with diffuse, mild hypoechogenicity
Fig. 3  Autoimmune thyroiditis. Longitudinal section: enlarged thy-
roid lobe with diffuse moderate hypoechogenicity, marked inhomoge-
neity with honeycomb appearance
Fig. 4  Autoimmune thyroiditis. Longitudinal section: enlarged thy-
roid lobe with diffuse, mild hypoechogenicity with pseudo-nodular 
appearance
Fig. 5    Autoimune thyroiditis. Transverse section: enlarged thyroid 
lobe with diffuse, moderate hypoechogenicity, marked inhomogene-
ity, with hypoechoic nodular area in the right lobe
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US report in subacute thyroiditis
The diagnosis of subacute or De Quervain thyroiditis is usu-
ally made on the basis of clinical symptoms of neck pain and 
fever, together with laboratory findings of thyrotoxicosis and 
inflammation. The typical appearance of subacute thyroiditis 
is a diffuse heterogeneity with the presence of patchy, poorly 
defined hypoechoic areas that can affect a portion of one or 
both lobes, an entire lobe, or the entire gland [28]. These 
ill-defined hypoechoic areas typically change and migrate 
during the active phase of the disease and disappear on 
remission. The affected part of the gland has a decreased 
blood flow at color and power Doppler examination (Fig. 4).
US report in nodular thyroid disease
Thyroid US is a mainstay in the clinical assessment of 
nodular thyroid disease [29]. Indeed, US is essential in 
monitoring nodule size and echostructure and US features 
help defining the risk of malignancy in thyroid nodules. 
The US report in nodular thyroid disease should be struc-
tured as described in Table 2.
US report in lymph nodes
Typical lymph node is characterized by a hypoechoic pat-
tern, oval shape and the presence of a central hyperechoic 
stroma corresponding to the hilum. Pathological lymph 
nodes have a cystic or solid pattern, iso- or hyperechoic with 
round or irregular shape, without hilum [37]. The position of 
lymph nodes that for their pattern deserve description must 
be precisely localized following the scheme of Robbins [38].
Table 4  US features and patterns associated with benignity
Completely anechoic texture (cystic nodules)
Mixed/spongiform texture
Oval shape
Iso/hyper echogenicity
Regular margins
Complete halo
Coarse macrocalcifications
Hyperechoic pseudo-nodular areas in thyroid autoimmune diseases
Coalescent iso/hyperechoic nodule in the context of goiter
High elasticity at elastosonography
Table 5  Risk category 1. Low risk Nodules with at least 2 US features associated with benig-
nity (Table 4) and no feature associated with malignancy 
(Table 6)
2. Intermediate risk Nodules with risk score 1–3
3. High risk Nodules with risk score ≥ 4
Table 6  US features associated 
with malignancy Low specificity, high reproducibility HypoechogenicityThick halo
Risk score 1
High specificity, poor reproducibility Microcalcifications
Irregular, disrupted, spiculated or 
lobulated margins
High stiffness at elastosonography
Risk score 2
High specificity, high reproducibility Marked hypoechogenicity
Irregular shape, including “taller than 
wide”
Risk score 3
Very high specificity, high reproducibility, acces-
sory features
Extra capsular extension
Suspicious lymph nodes
Risk score 4
Fig. 6  Thyroid nodule with low risk: longitudinal section of right 
lobe. Isoechoic nodule with halo sign and cystic area
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Risk stratification of thyroid nodules (Figs. 6, 7, 8, 9, 
10, 11)
Indications for fine needle aspiration are based on the US 
evaluation of risk of malignancy that should be scored 
in each nodule. As several risk stratification systems for 
thyroid nodules are published, the report should include 
the reference of the system used.
US features and patterns suggestive of benignity are 
summarized in Table 4. In this consensus, we propose a 
simplified nodule risk stratification (Table 5), based on 
the predictive value of each US sign, classified and scored 
according to the strength of association with malignancy, 
but also to the estimated reproducibility among different 
operators (Table 6).     
Conclusive remarks
Autoimmune and nodular thyroid diseases, especially in 
subclinical forms, are extremely frequent. Thyroid US is 
nowadays widely used as first diagnostic approach in such 
patients. The peculiar pattern of thyroid US of patients 
with Hashimoto’s thyroiditis and Graves’ disease is easily 
recognizable by most operators, but the terminology used 
to describe these patterns is not uniform, possibly causing 
misunderstandings in the interpretation of the reports. In the 
last years, several papers were focused on the possibility to 
Fig. 7  Thyroid nodule with intermediate risk (risk score 2): longitudi-
nal section of right lobe. Isoechoic nodule with thick halo and spicu-
lated margins
Fig. 8  Thyroid nodule with high risk (risk score > 4): transverse sec-
tion of right lobe. Inhomogeneous hypoechoic nodule with irregular 
margins, taller than wide shape and extracapsular extension
Fig. 9  Thyroid nodule with high risk (risk score > 4): longitudinal 
section of right lobe. Hypoechoic nodule with irregular shape and 
spiculated margins
Fig. 10  Thyroid nodule with high risk (risk score > 4): Longitudinal 
section of right lobe. Inhomogeneous hypoechoic nodule with irregu-
lar margins and anechoic area
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stratify the risk of cancer in thyroid nodules, based on US 
features. Accordingly, scientific societies of endocrinologists 
and radiologists have drawn up guidelines and consensus 
statements inspired by the TIRADS system used for breast 
cancer. The plethora of these systems and in some cases their 
complexity have hampered their use in the clinical practice.
We propose here a consensus agreed by Italian scientific 
societies that collect specialists who deal with the diagnostic 
management of thyroid patients. At difference with previous 
publications, autoimmune thyroid diseases and subacute thy-
roiditis are included together with nodular thyroid diseases 
in the suggestion of a standardized reporting.
The hope of participating societies is that the indications 
contained in this consensus will be adopted by most spe-
cialists who deal with thyroid diseases, with the result of 
decreasing the ambiguity and inhomogeneity of thyroid US 
reporting.
Compliance with ethical standards 
Conflict of interest The authors have nothing to disclose.
Ethical approval This article does not contain any studies with human 
participants or animals performed by any of the authors.
Informed consent No informed consent.
References
 1. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera 
A (1991) Thyroid ultrasonography helps to identify patients with 
diffuse lymphocytic thyroiditis who are prone to develop hypo-
thyroidism. J Clin Endocrinol Metab 72:209–213. https ://doi.
org/10.1210/jcem-72-1-209
 2. Vitti P, Lampis M, Piga M, Loviselli A, Brogioni S, Rago T, 
Pinchera A, Martino E (1999) Diagnostic usefulness of thy-
roid ultrasonography in atrophic thyroiditis. J Clin Ultrasound 
22:375–379
 3. Vitti P, Rago T, Mancusi F, Pallini S, Tonacchera M, Santini F, 
Chiovato L, Marcocci C, Pinchera A (1992) Thyroid hypoecho-
genic pattern at ultrasonography as a tool for predicting recur-
rence of hyperthyroidism after medical treatment in patients 
with Graves’ disease. Acta Endocrinol 126:128–131 PMID: 
1543017
 4. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi 
R, Martino E, Pinchera A (1997) Clinical features of patients with 
Graves’ disease undergoing remission after antithyroid drug treat-
ment. Thyroid. 7:369–375. https ://doi.org/10.1089/thy.1997.7.369
 5. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 Ameri-
can thyroid association management guidelines for adult patients 
with thyroid nodules and differentiated thyroid cancer: the Ameri-
can thyroid association guidelines task force on thyroid nodules 
and differentiated thyroid cancer. Thyroid 26:1–133. https ://doi.
org/10.1089/thy.2015.0020
 6. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs 
L, Paschke R, Valcavi R, Vitti P, on behalf of the AACE/ACE/
AME Task Force on Thyroid Nodules (2016) American associa-
tion of Clinical endocrinologists, American college of Endocrinol-
ogy and Associarione medici endocrinologi medical guidelines 
for clinical practice for the diagnosis and management of thyroid 
nodules 2016 update. Endocr Pract. https ://doi.org/10.4158/EP161 
208.GL
 7. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt 
L (2017) European thyroid association guidelines for ultrasound 
malignancy risk stratification of thyroid nodules in adults: the EU-
TIRADS. Eur Thyroid J 6:225–237. https ://doi.org/10.1159/00047 
8927
 8. Knobel M (2016) Etiopathology, clinical features and treatment 
of diffuse and multinodular goiters. J Endocrinol Investig 39:357–
373. https ://doi.org/10.1007/s4061 8-015-0391-7
 9. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi 
A, Bartolozzi C, Pinchera A, Martino E (1995) Thyroid blood 
flow evaluation by color-flow Doppler sonography distinguishes 
Graves’ disease from Hashimoto’s thyroiditis. J Endocrinol Inves-
tig 18:857–861. https ://doi.org/10.1007/BF033 49833 
 10. Rago T, Chiovato L, Aghini-Lombardi F, Grasso L, Pinchera 
A, Vitti P (2001) Non-palpable thyroid nodules in a borderline 
iodine-sufficient area: detection by ultrasonography and follow-up. 
J Endocrinol Investig 24:770–776. https ://doi.org/10.1007/BF033 
43926 
 11. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, 
Vik-Mo H (2000) The value of ultrasonography in predicting 
autoimmune thyroid disease. Thyroid 10(3):251–259. https ://doi.
org/10.1089/thy.2000.10.251
Fig. 11  Thyroid nodule with 
high risk (risk score > 4): 
transverse and longitudinal 
section of left lobe. Inhomoge-
neous hypoechoic nodule with 
irregular margins, taller than 
wide shape and extracapsular 
extension
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
     
    R
EV
ISE
D P
RO
OF
Journal : Large 40618 Article No : 935 Pages : 9 MS Code : JENI-D-18-00315 Dispatch : 11-10-2018
Journal of Endocrinological Investigation 
1 3
 12. Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P (2001) Thy-
roid ultrasonography as a tool for detecting thyroid autoimmune 
diseases and predicting thyroid disfunction in apparently healthy 
subjects. J Endocrinol Investig 24:763–769 (PMID: 11765045)
 13. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, 
Coleman BG et al (2005) Management of thyroid nodules detected 
at US: Society of Radiologists in Ultrasound consensus confer-
ence statement. Radiology 237:794–800. https ://doi.org/10.1148/
radio l.23730 50220 
 14. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccagna S, 
Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM (2002) 
Risk of malignancy in nonpalpable thyroid nodules: predictive 
value of ultrasound and color-Doppler features. J Clin Endocrinol 
Metab 87:1941–1944. https ://doi.org/10.1210/jcem.87.5.8504
 15. Mandel SJ (2004) Diagnostic use of ultrasonography in patients 
with nodular thyroid disease. Endocr Pract 10:246–252. https ://
doi.org/10.4158/EP.10.3.246
 16. Khoo ML, Asa SL, Witterick IJ, Freeman JL (2002) Thyroid cal-
cification and its association with thyroid carcinoma. Head Neck 
24:651–655. https ://doi.org/10.1002/hed.10115 
 17. Kim EK, Park CS, Chung WY et al (2002) New sonographic cri-
teria for recommending fine-needle aspiration biopsy of non pal-
pable solid nodules of the thyroid. Am J Roentgenol 178:687–691. 
https ://doi.org/10.2214/ajr.178.3.17806 87
 18. Peccin S, de Castro JA, Furlanetto TW, Furtado AP, Brasil BA, 
Czepielewski MA (2002) Ultrasonography: is it useful in the 
diagnosis of cancer in thyroid nodules? J Endocrinol Investig 
25:39–43 (PMID:11885575)
 19. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, 
Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Ham-
mers LW, Hamper UM, Langer JE, Reading CC, Scoutt LM, Stav-
ros AT (2017) ACR thyroid imaging, reporting and data system 
(TI-RADS): white paper of the ACR TI-RADS committee. J Am 
Coll Radiol 14:587–595
 20. Horvath E, Majlis S, Rossi R et al (2009) An ultrasonogram 
reporting system for thyroid nodules stratifying cancer risk for 
clinical management. J Clin Endocrinol Metab 94:1748–1751. 
https ://doi.org/10.1210/jc.2008-1724
 21. Kwak JY, Han KH, Yoon JH et al (2011) Thyroid imaging report-
ing and data system for US features of nodules: a step in establish-
ing better stratification of cancer risk. Radiology 260:892–899. 
https ://doi.org/10.1148/radio l.11110 206
 22. Na DG, Baek JH, Sung JY et al (2016) Thyroid imaging reporting 
and data system risk stratification of thyroid nodules: categori-
zation based on solidity and echogenicity. Thyroid 26:562–572. 
https ://doi.org/10.1089/thy.2015.0460
 23. Park JY, Lee HJ, Jang HW et al (2009) A proposal for a thyroid 
imaging reporting and data system for ultrasound features of thy-
roid carcinoma. Thyroid 19:1257–1264. https ://doi.org/10.1089/
thy.2008.0021
 24. Seo H, Na DG, Kim JH, Kim KW, Yoon JW (2015) Ultrasound-
based risk stratification for malignancy in thyroid nodules: a four-
tier categorization system. Eur Radiol 25:2153–2162
 25. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, Lim HK, 
Moon WJ, Na DG, Park JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, 
Kim DW, Kim EK, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, 
Lee KH, Park SW, Sung JY, Korean Society of Thyroid Radiology 
(KSThR) and Korean Society of Radiology (2016) Ultrasonogra-
phy diagnosis and imaging-based management of thyroid nodules: 
revised Korean society of thyroid radiology consensus statement 
and recommendations. Korean J Radiol 17(3):370–395. https ://
doi.org/10.3348/kjr.2016
 26. Persichetti A, Di Stasio E, Guglielmi R, Bizzarri G, Taccogna S, 
Misischi I, Graziano F, Petrucci L, Bianchini A, Papini E (2018) 
Predictive value of malignancy of thyroid nodule ultrasound clas-
sification systems: a prospective study. J Clin Endocrinol Metab 
103:1359–1368. https ://doi.org/10.1210/jc.2017-01708 
 27. Maino F, Forleo R, Martinelli M, Fralassi N, Barbato F, Pilli T, 
Capezzone M, Brilli L, Ciuoli C, G Cairano G, Nigi L, Pacini F, 
Castagna MG (2018) Prospective validation of ATA and ETA 
sonographic pattern risk of thyroid nodules selected for FNAC. J 
Clin Endocrinol Metab 103:2362–2368. https ://doi.org/10.1210/
jc.2018-00274 
 28. Bogazzi F, Dell’Unto E, Tanda ML, Tomisti L, Cosci C, Aghini-
Lombardi F, Sardella C, Pinchera A, Bartalena L, Martino E 
(2006) Long-term outcome of thyroid function after amiodar-
one-induced thyrotoxicosis, as compared to subacute thyroiditis. 
J Endocrinol Investig 29:694–699. https ://doi.org/10.1007/bf033 
44178 
 29. Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A 
(2014) Quantification of cancer risk of each clinical and ultra-
sonographic suspicious feature of thyroid nodules: a systematic 
review and meta-analysis. Eur J Endocrinol 170:203–211. https 
://doi.org/10.1530/EJE-13-0995
 30. Rago T, Santini F, Scutari M, Pinchera A, Vitti P (2007) Elastog-
raphy: new developments in ultrasound for predicting malignancy 
in thyroid nodules. J Clin Endocrinol Metab 92:2917–2922. https 
://doi.org/10.1210/jc.2007-0641
 31. Magri F, Chytiris S, Capelli V, Gaiti M, Zerbini F, Carrara R, 
Malovini A, Rotondi M, Bellazzi R, Chiovato L (2013) Compari-
son of elastographic strain index and thyroid fine-needle aspira-
tion cytology in 631 thyroid nodules. J Clin Endocrinol Metab 
12:4790–4797. https ://doi.org/10.1210/jc.2013-2672
 32. Cantisani V, Consorti F, Guerrisi A, Guerrisi I, Ricci P, Di Segni 
M, Mancuso E, Scardella L, Milazzo F, D’Ambrosio F, Antonaci 
A (2013) Prospective comparative evaluation of quantitative-elas-
tosonography (Q-elastography) and contrast-enhanced ultrasound 
for the evaluation of thyroid nodules: preliminary experience. 
Eur J Radiol 82(11):1892–1898. https ://doi.org/10.1016/j.ejrad 
.2013.07.005
 33. Hegedus L (2010) Can elastography stretch our understanding 
of thyroid histomorphology? J Clin Endocrinol Metab 95:5213–
5215. https ://doi.org/10.1210/jc.2010-2411
 34. Chandramohan A, Therese M, Abhraham D, Paul TV, Mazhuvan-
chary PJ (2018) Can ARFI elastography be used to differentiate 
parathyroid from thyroid lesions? J Endocrinol Investig 41:111–
119. https ://doi.org/10.1007/s4061 8-017-0694-y
 35. Cosgrove D, Barr R, Bojunga J, Cantisani V, Chammas MC, 
Dighe M, Vinayak S, Xu JM, Dietrich CF (2017) WFUMB guide-
lines and recommendations on the clinical use of ultrasound elas-
tography. Ultrasound Med Biol 43:4–26. https ://doi.org/10.1016/j.
ultra smedb io.2016.06.022
 36. Rago T, Vitti P, Chiovato L, Mazzeo S, De Liperi A, Miccoli P, 
Viacava P, Bogazzi F, Martino E, Pinchera A (1998) Role of con-
ventional ultrasonography and color flow-doppler sonography in 
predicting malignancy in ‘cold’ thyroid nodules. Eur J Endocrinol 
38:41–46 (PMID: 9461314)
 37. Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, 
Rago T, Russ G (2013) 2013 European thyroid association guide-
lines for cervical ultrasound scan and ultrasound-guided tech-
niques in the postoperative management of patients with thyroid 
cancer. Eur Thyroid J 2:147–159. https ://doi.org/10.1159/00035 
4537
 38. Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito 
A, Som PM, Day TA (2008) Consensus statement on the clas-
sification and terminology of neck dissection. Arch Otolaryngol 
Head Neck Surg 134:536–538. https ://doi.org/10.1001/archo 
tol.134.5.536
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
